Functional and cognitive criteria produce different rates of mild cognitive impairment and conversion to dementia

J Saxton1, B E Snitz, O L Lopez

  • 1Department of Neurology, University of Pittsburgh, 3471 Fifth Avenue, Suite 811, Pittsburgh, PA 15213, USA. saxtonja@upmc.edu

Abstract

Insights

Different diagnostic criteria for mild cognitive impairment (MCI) yield varying prevalence and dementia conversion rates. Neuropsychological (NP) criteria identified fewer MCI cases but showed higher progression to dementia compared to the Clinical Dementia Rating (CDR).

Area of Science:

  • Neurology
  • Gerontology
  • Cognitive Science

Background:

  • Mild cognitive impairment (MCI) is a transitional stage between normal aging and dementia.
  • Accurate diagnosis of MCI is crucial for early intervention and understanding disease progression.
  • Various diagnostic systems exist, potentially leading to discrepancies in identification and prognosis.

Purpose of the Study:

  • To compare the rates of mild cognitive impairment (MCI) and subsequent progression to dementia using distinct diagnostic criteria.
  • To evaluate the concordance and discordance between the Clinical Dementia Rating (CDR) and neuropsychological (NP) criteria for MCI.
  • To identify factors associated with MCI diagnoses and their predictive value for dementia development.

Main Methods:

  • The Ginkgo Evaluation of Memory (GEM) study enrolled 3063 non-demented elderly individuals.
  • MCI was assessed at baseline using both CDR (score of 0.5) and NP criteria (standard cognitive tests).
  • Participants were followed for dementia development over a median of 6.1 years.

Main Results:

  • 40.2% met CDR MCI criteria, while 28.2% met NP MCI criteria; only 15.7% met both.
  • Significant discordance was observed, with 24.5% classified as NP normal/CDR MCI and 12.4% as NP MCI/CDR normal.
  • Individuals diagnosed with NP MCI but CDR normal were more likely to progress to dementia.

Conclusions:

  • Different MCI diagnostic systems result in varied prevalence and dementia conversion rates.
  • While CDR identifies more MCI cases, NP criteria better predict progression to dementia.
  • CDR may capture subtle cognitive changes but is also susceptible to demographic and clinical confounders, suggesting caution in its sole use for diagnosing Alzheimer's disease.

Related Concept Videos

Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function. They...